Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: Nonrenal excretion of serum methotrexate

Medical and Pediatric Oncology

Volumn 34, Issue 3, 2000, Pages 226-228

  Shinozaki, Tetsuya ^a   Watanabe, Hideomi ^a   Tomidokoro, Rie ^b   Yamamoto, Koujirou ^a   Horiuchi, Ryuya ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cholestyramine rescue; High dose methotrexate; Nephrotoxicity

Indexed keywords

COLESTYRAMINE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG MEGADOSE; HUMAN; MALE; NEPHROTOXICITY; OSTEOSARCOMA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0034051653     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-911x(200003)34:3<226::aid-mpo15>3.0.co;2-%23     Document Type: Article

References (8)

1. Goldman ID, Gupta V, White JC, et al. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high-dose methotrexate-folic acid rescue protocols. Cancer Res 1976;36:276-279.
2. Rosen G, Nirenberg A. High-dose methotrexate with calcium leucovorin rescue: a practical guide to its safe and effective use. In Kimura K, Wang Y-M, (eds): "Progress in Cancer Research and Therapy, vol. 33; Methotrexate in Cancer Therapy." New York: Raven Press, 1986, pp. 103-116.
3. Lui CY, Lee MG, Chiou WL. Clearance studies of methotrexate in dogs after multiple-rate infusion. Cancer Res 1985;45:1545-1548.
4. Yamamoto K, Sawada Y, Matsushita Y, et al. Delayed elimination of methotrexate associated with piperacillin administration. Ann Pharmacother 1997;31:1261-1262.
5. Ahmad S., Shen F, Bleyer WA.: Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med 1978;138:1146-1147.
6. Kepka L, Lassence AD, Ribrag V, et al. Successful rescue in a patient with high dose methotrexate-induced nephrotoxitcity and acute renal failure. Leukemia Lymphoma 1998;29:205-209.
7. Erttmann R, Landbeck G. Effects of oral cholestyramine on the elimination of high-dose methotrexate. J Cancer Res Oncol 1985; 110:48-50.
8. Relling MV, Stapleton B., Ochs J, et al. Removal of methotrexate, leucovorin, and their metabolites by combined hemodyalysis and hemoperfusion. Cancer 1988;62:884-888, 1988.